Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 AUD | +2.27% | +1.12% | +30.43% |
May. 17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
May. 15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
Sales 2024 * | 3.55M 2.36M | Sales 2025 * | 14.85M 9.88M | Capitalization | 535M 356M |
---|---|---|---|---|---|
Net income 2024 * | -45M -29.93M | Net income 2025 * | -44M -29.27M | EV / Sales 2024 * | 130 x |
Net cash position 2024 * | 75.11M 49.96M | Net cash position 2025 * | 61.67M 41.02M | EV / Sales 2025 * | 31.9 x |
P/E ratio 2024 * |
-11.8
x | P/E ratio 2025 * |
-12.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.19% |
1 day | +2.27% | ||
1 week | +1.12% | ||
1 month | +4.65% | ||
3 months | +23.29% | ||
6 months | +52.54% | ||
Current year | +30.43% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 51 | 10-12-31 |
David Fang
DFI | Director of Finance/CFO | - | 18-02-28 |
Florian Vogl
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Howard
CHM | Chairman | 74 | 13-05-07 |
Marc Voigt
CEO | Chief Executive Officer | 51 | 10-12-31 |
Anne Anderson
BRD | Director/Board Member | - | Feb. 13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.45 | +2.27% | 2,195,050 |
24-05-30 | 0.44 | -.--% | 2,081,315 |
24-05-29 | 0.44 | -.--% | 418,498 |
24-05-28 | 0.44 | -2.22% | 1,162,891 |
24-05-27 | 0.45 | +1.12% | 968,327 |
Delayed Quote Australian S.E., May 31, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.43% | 355M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- IMM Stock